Double maintains 1 strategies that include KALV - KalVista Pharmaceuticals, Inc.
Current Value
$11.461 Year Return
Current Value
$11.461 Year Return
Yahoo
CAMBRIDGE, Mass. & SALISBURY, England, July 02, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista’s board of directors granted five newly-hired employees inducement options to purchase an aggregate of 23,000 shares of KalVista common stock on July 1, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock on th
Finnhub
Pendopharm®?, a division of Pharmascience Inc., has entered into an exclusive distribution agreement with KalVista Pharmaceuticals, Inc. This agreement grants Pendopharm®? the rights to manage...
Yahoo
Pendopharm®, a division of Pharmascience Inc., has entered into an exclusive distribution agreement with KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a global biopharmaceutical company focused on the development of novel oral treatments for rare diseases. This agreement grants Pendopharm® the rights to manage regulatory approval and commercialization of sebetralstat, an investigational oral therapy for Hereditary Angioedema (HAE), developed by KalVista® in Canada. Financial details of the agre
Yahoo
CAMBRIDGE, Mass. & SALISBURY, England, June 26, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that its wholly-owned subsidiary, KalVista Pharmaceuticals, Ltd., has granted Pendopharm, a division of Pharmascience Inc., the exclusive rights to manage the regulatory approval process and commercialization of sebetralstat in Canada. Sebetralstat is an investigational, oral on-demand treatment for hereditary angioedema (HAE).
Yahoo
Biotech stock KalVista has soared recently, as the firm looks to fundamentally change the treatment landscape for HAE patients.
Finnhub
CAMBRIDGE, SALISBURY, England - KalVista Pharmaceuticals, Inc. announced the presentation of new data at the European Academy of Allergy and Clinical Immunology Congress 2025 in Glasgow, United...
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -28.72% | $164.54M | 0.85% |
| BTAL | -25.40% | $296.22M | 1.43% |
| TAIL | -24.62% | $99.63M | 0.59% |
| SHYM | -9.73% | $357.13M | 0.35% |
| TPMN | -7.50% | $30.70M | 0.65% |
| CLIP | -6.98% | $1.51B | 0.07% |
| ULST | -6.78% | $654.75M | 0.2% |
| STOT | -6.33% | $254.07M | 0.45% |
| IVOL | -5.96% | $347.03M | 1.02% |
| USDU | -5.54% | $162.43M | 0.5% |
| UUP | -5.36% | $201.63M | 0.77% |
| SMB | -5.25% | $274.97M | 0.07% |
| VRIG | -4.95% | $1.21B | 0.3% |
| WEAT | -4.87% | $117.15M | 0.28% |
| TFLO | -4.41% | $6.82B | 0.15% |
| LMBS | -4.06% | $5.11B | 0.64% |
| SPTS | -3.81% | $5.80B | 0.03% |
| SHYD | -3.71% | $332.63M | 0.35% |
| DFNM | -3.44% | $1.57B | 0.17% |
| UNG | -3.25% | $360.54M | 1.06% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 52.99% | $4.82B | 0.35% |
| IBB | 49.19% | $5.26B | 0.45% |
| PTH | 49.07% | $100.85M | 0.6% |
| GNOM | 47.88% | $44.57M | 0.5% |
| ARKG | 46.48% | $1.02B | 0.75% |
| PBE | 45.69% | $223.19M | 0.58% |
| IWC | 43.94% | $818.14M | 0.6% |
| XPH | 43.71% | $147.96M | 0.35% |
| IWO | 42.96% | $11.60B | 0.24% |
| BBH | 42.62% | $330.62M | 0.35% |
| IWM | 41.68% | $63.72B | 0.19% |
| VTWO | 41.56% | $12.52B | 0.07% |
| KJUL | 41.23% | $119.50M | 0.79% |
| FBT | 40.54% | $1.01B | 0.54% |
| PINK | 40.18% | $130.57M | 0.5% |
| KJAN | 39.42% | $287.30M | 0.79% |
| IWMY | 39.35% | $119.32M | 1.02% |
| KOMP | 39.20% | $2.29B | 0.2% |
| IJT | 39.06% | $6.06B | 0.18% |
| SCHA | 38.87% | $17.26B | 0.04% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IDYA | 46.00% | $1.92B | -34.15% | 0.00% |
| IRON | 44.29% | $1.84B | +19.67% | 0.00% |
| ATXS | 44.11% | $323.37M | -36.33% | 0.00% |
| CRSP | 42.37% | $4.46B | -4.14% | 0.00% |
| KYMR | 41.90% | $3.12B | +47.65% | 0.00% |
| OCUL | 41.89% | $1.51B | +41.41% | 0.00% |
| FATE | 41.61% | $128.39M | -64.56% | 0.00% |
| IMNM | 41.10% | $750.92M | -28.80% | 0.00% |
| SYRE | 41.09% | $935.48M | -39.83% | 0.00% |
| RXRX | 39.87% | $2.12B | -29.12% | 0.00% |
| CGON | 39.76% | $2.03B | -13.46% | 0.00% |
| TWST | 39.72% | $2.26B | -21.50% | 0.00% |
| ARWR | 39.38% | $2.33B | -32.59% | 0.00% |
| AUTL | 39.37% | $625.43M | -32.66% | 0.00% |
| DNLI | 39.22% | $2.16B | -30.05% | 0.00% |
| KRYS | 39.01% | $4.08B | -20.39% | 0.00% |
| ESTA | 38.86% | $1.28B | +1.44% | 0.00% |
| RYTM | 38.71% | $4.26B | +63.98% | 0.00% |
| APLS | 38.63% | $2.24B | -49.68% | 0.00% |
| CRNX | 38.49% | $2.76B | -33.39% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -13.39% | $24.23B | +35.36% | 1.09% |
| ACHC | -10.41% | $2.14B | -65.25% | 0.00% |
| UUU | -9.90% | $7.17M | +101.30% | 0.00% |
| LITB | -8.74% | $21.24M | -78.57% | 0.00% |
| K | -7.98% | $27.76B | +41.17% | 2.85% |
| VSTA | -6.91% | $344.07M | +39.29% | 0.00% |
| HUSA | -6.38% | $19.66M | -19.53% | 0.00% |
| ZCMD | -6.11% | $29.55M | -8.59% | 0.00% |
| STG | -5.45% | $30.78M | -22.51% | 0.00% |
| FATBB | -4.85% | $49.01M | -5.66% | 10.18% |
| PRPO | -4.38% | $17.08M | +125.94% | 0.00% |
| ED | -3.54% | $36.00B | +12.64% | 3.34% |
| ETR | -3.45% | $35.03B | +54.09% | 4.33% |
| NEUE | -3.22% | $61.24M | +29.92% | 0.00% |
| PSQH | -3.11% | $98.82M | -36.55% | 0.00% |
| BTCT | -3.00% | $25.56M | +61.14% | 0.00% |
| RLX | -2.78% | $2.13B | +27.17% | 0.42% |
| CCRN | -2.69% | $429.13M | -3.89% | 0.00% |
| CYCN | -2.59% | $10.59M | +46.35% | 0.00% |
| FUBO | -1.83% | $1.25B | +178.63% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CNK | 0.14% | $3.47B | +41.29% | 0.53% |
| ARLP | -0.17% | $3.42B | +6.48% | 10.66% |
| DOGZ | -0.17% | $121.58M | -48.38% | 0.00% |
| RILY | 0.28% | $98.51M | -80.97% | 0.00% |
| FDP | 0.47% | $1.59B | +52.62% | 3.31% |
| CME | -0.49% | $99.39B | +40.68% | 3.86% |
| VZ | 0.51% | $183.79B | +6.01% | 6.18% |
| PEG | 0.54% | $40.53B | +9.77% | 3.03% |
| KNOP | 0.59% | $229.79M | -18.98% | 1.56% |
| MNOV | 0.68% | $62.29M | -9.29% | 0.00% |
| CNP | 0.68% | $23.35B | +17.94% | 2.36% |
| IMNN | -0.73% | $16.26M | -34.16% | 0.00% |
| LRN | 0.78% | $5.99B | +100.06% | 0.00% |
| DXCM | 0.83% | $32.77B | -24.64% | 0.00% |
| XBIO | 0.87% | $6.08M | +5.25% | 0.00% |
| NEXA | -0.98% | $659.55M | -36.15% | 0.00% |
| CPSH | -1.01% | $42.27M | +74.25% | 0.00% |
| LTM | -1.02% | $12.63B | -95.46% | 2.42% |
| AEP | 1.13% | $55.16B | +17.93% | 3.54% |
| XEL | 1.15% | $38.97B | +28.08% | 3.30% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| AGZ | <0.01% | $614.58M | 0.2% |
| XONE | 0.02% | $625.28M | 0.03% |
| CORN | 0.16% | $44.67M | 0.2% |
| USTB | 0.24% | $1.29B | 0.35% |
| UTWO | 0.24% | $379.52M | 0.15% |
| IBD | -0.35% | $385.27M | 0.43% |
| GOVZ | -0.37% | $272.00M | 0.1% |
| FLGV | 0.42% | $1.03B | 0.09% |
| IBTM | 0.44% | $316.49M | 0.07% |
| BUXX | 0.45% | $315.18M | 0.25% |
| PALL | 0.49% | $515.28M | 0.6% |
| IBTH | -0.50% | $1.62B | 0.07% |
| PSQA | 0.53% | $35.44M | 0.2% |
| GOVT | 0.56% | $27.54B | 0.05% |
| STXT | 0.56% | $129.40M | 0.49% |
| SCHO | 0.64% | $11.03B | 0.03% |
| FMHI | 0.69% | $754.85M | 0.7% |
| STPZ | 0.71% | $450.47M | 0.2% |
| IBTG | 0.76% | $1.92B | 0.07% |
| OWNS | 0.83% | $129.31M | 0.3% |
